Section 174 & 174A · Brief · Pro level
Section 174 in partnerships: entity-level capitalization and what the K-1 actually shows
SRE expenditures are capitalized or deducted at the partnership level, not by the partners — the partnership's method controls, and partners see the results baked into their distributive share of ordinary income. Section 704(b) allocations, built-in 704(c) items, and tiered structures each add their own wrinkle.
Section 174 runs at the partnership level. Under Section 703(b), elections and accounting methods affecting the computation of taxable income are made by the partnership, so it is the entity that identifies specified research or experimental (SRE) expenditures, sorts them between domestic deduction under Section 174A and 15-year foreign amortization under Section 174, and files any Form 3115 to change treatment. Partners inherit the outcome inside ordinary income on the K-1; they do not get to reclassify it.
Entity-level mechanics, partner-level consequences
During 2022–2024, a research-heavy partnership that had been deducting development costs suddenly reported income (or smaller losses) as capitalization took hold — the same cash-versus-taxable-income squeeze corporations felt, described in Section 174 explained, but delivered to partners as phantom income on which they owed tax personally. The OBBBA reversed the squeeze for domestic costs: the partnership deducts currently under Section 174A, and the entity-level choices — the one- or two-year catch-up for remaining 2022–2024 balances, or the small-business retroactive route — are the partnership's to make. A partnership under the $31 million gross-receipts ceiling makes the retroactive election at the entity level, and fixing already-filed years runs through the BBA's administrative adjustment request machinery rather than partner amended returns.
Two partner-level facts follow from entity-level capitalization. Each partner's outside basis and Section 704(b) capital account went up by its share of the income the disallowed deductions created — basis that returns as amortization deductions flow through later. And a partner who sells its interest mid-schedule walks away from the remaining amortization economically; absent a Section 754 election, the buyer of the interest gets no adjustment putting it right. With a 754 election in place, the Section 743(b) basis adjustment is personal to the transferee and recovers on its own track.
Section 704(b) and 704(c) wrinkles
Allocations of the capitalization-era income, and of the amortization now unwinding it, must have substantial economic effect under Section 704(b) and Treas. Reg. §1.704-1 (eCFR Title 26). The awkward pattern: a deal that specially allocated deductions to the money partner found those deductions transformed into capitalized amounts, with the later amortization following the same special allocation only if the agreement's language reached it. Agreements drafted pre-2022 rarely contemplated the question.
Section 704(c) adds a layering problem. IP contributed to the partnership with built-in gain carries that gain back to the contributor; but SRE costs the partnership incurs after contribution are common items shared under the general ratios. A contributing founder can thus watch new partners absorb the capitalization income on development of technology the founder built — and later collect the matching amortization.
Tiered structures and the K-1 view
In tiers, each partnership applies Section 174 to its own expenditures; a lower-tier operating entity's capitalization flows up through ordinary income at each level. The gross-receipts tests for the retroactive small-business election aggregate under Section 448(c) principles, so a fund structure can blow the ceiling for an operating subsidiary that looks small on its own.
What the K-1 separately states — and what it hides:
| Item | Separately stated? | Where it appears |
|---|---|---|
| 174/174A deduction or amortization | No | Inside line 1 ordinary income |
| Section 41 research credit | Yes | Box 15, partner applies own limits |
| Section 481(a) catch-up from a 174 method change | No | Inside line 1, year of change |
The contrast with the credit is the practical trap: the Section 41 credit is separately stated so each partner can run its own general-business-credit limitations, while the 174 treatment that generates the same costs is invisible on the K-1 face. Partners doing their own planning — estimated taxes, basis tracking, state conformity — need the entity's workpapers, not the form.
Frequently asked questions
- Are Section 174 costs capitalized at the partnership level or the partner level?
- At the partnership level. Section 703(b) places accounting-method decisions and most elections with the entity, so the partnership decides whether costs are SRE expenditures, applies the domestic-versus-foreign amortization rules, and elects (or not) Section 174A capitalization. Partners receive the after-effect through ordinary income on the K-1; they cannot re-decide the characterization on their own returns.
- Do partners see Section 174 amortization as a separate line on Schedule K-1?
- Generally no. Unlike the Section 41 research credit, which is separately stated so each partner can apply its own limitations, 174 or 174A amounts are components of the partnership's ordinary business income on line 1. A partner cannot tell from the K-1 face how much capitalized research sits inside the number — that requires the partnership's workpapers.
- How did TCJA-era capitalization affect partners with Section 704(c) layers?
- Capitalization raised partnership taxable income during 2022–2024 without raising cash, and those allocations increased partners' outside basis and capital accounts unevenly where special allocations or 704(c) layers applied. A partner contributing appreciated IP also carries built-in gain that reverses to it — the 174 balance from post-contribution development, by contrast, is a common item allocated under the general 704(b) sharing ratios.